Core Insights - GBT Technologies, Inc. has announced the acquisition of twenty-three additional AI-driven health and wellness machines through its subsidiary, Cube Wellness Technologies, expanding its total to thirty-six machines [1][2] Company Overview - GBT Technologies, Inc. is focused on developing technologies in artificial intelligence (AI), Internet of Things (IoT), and intelligent platform technologies, aiming for scalable commercial applications [6] - Cube Wellness Technologies, a wholly-owned subsidiary of GBT, specializes in deploying AI-enabled automated wellness infrastructure, providing 24/7 access to health-related products [7] Expansion and Strategy - The acquisition of new machines is part of Cube Wellness' initiative to establish a scalable wellness delivery network across universities and student-focused environments nationwide [2][3] - The newly acquired machines will feature intelligent inventory management, real-time system monitoring, digital payment technologies, and data-enabled operational controls [3] - Management views this expansion as a significant milestone in transitioning Cube Wellness from initial deployment to scalable growth [4] Future Outlook - The CEO of GBT emphasizes that expanding the platform to thirty-six machines is a crucial step in building a national digital wellness infrastructure [5] - The company aims to create a technology-driven platform that enhances access to wellness services in universities and institutional environments, positioning itself within the growing sectors of healthcare access and AI-enabled retail delivery [5]

Core Viewpoint - Black Hills Corp. has filed a rate review application with the South Dakota Public Utilities Commission to recover capital infrastructure and operational costs for providing electric service to approximately 75,000 customers [1][2]. Group 1: Rate Review Application - The company is seeking $50.6 million in new annual revenue to recover about $523 million in critical investments made since the last rate review in 2014 [2]. - The investments aim to strengthen the electric grid, maintain reliability, and reduce wildfire risk [2]. Group 2: Company Background and Financial Structure - Black Hills Corp. has maintained unchanged base rates for over a decade while ensuring safe and reliable service for its customers [3]. - The capital structure for the rate review is composed of 53.2% equity and 46.8% debt, with a targeted return on equity of 10.5% [3]. - The company is requesting interim rates to take effect 180 days after the filing, with new rates expected to be finalized in the first quarter of 2027 [3]. Group 3: Company Overview - Black Hills Corp. is a growth-oriented utility company serving 1.37 million natural gas and electric utility customers across eight states [4].

Core Insights - Quantum Leap Energy LLC (QLE), a subsidiary of ASP Isotopes Inc. (ASPI), has established a Strategic Advisory Board (SAB) to enhance its capabilities in the nuclear fuel cycle [1][3] - The SAB includes industry leaders Mary Lou Dunzik-Gougar and Kevin Kramer, who bring extensive expertise in nuclear engineering and advanced materials [1][4][5] - QLE is focused on developing proprietary technologies to address inefficiencies and environmental concerns in the nuclear fuel cycle, emphasizing modular and scalable designs [2][6] Company Overview - QLE is dedicated to advancing technologies across critical segments of the nuclear fuel cycle, including uranium conversion and isotopic separation [7][8] - The company aims to fill gaps in the nuclear fuel supply chain for advanced reactors and fusion systems through exclusive rights to proprietary technologies [8] - ASP Isotopes Inc. focuses on producing isotopes for various industries, with an initial emphasis on healthcare and technology, and plans to enrich isotopes for the nuclear energy sector [9] Strategic Initiatives - The formation of the SAB is seen as a significant step in QLE's commercial evolution, expected to accelerate market entry and deepen strategic partnerships [3] - QLE intends to leverage ASPI's proprietary isotope separation technologies, which offer advantages such as reduced capital expenditure and enhanced flexibility [6] - The company has established partnerships with industry leaders like TerraPower and Fermi America to accelerate the commercialization of critical isotopes [8]

Core Insights - Ultrack Systems Inc.'s subsidiary, Better Pets, has made significant advancements in 2025, focusing on regulatory, branding, commercialization, and digital transformation milestones to expand in the growing global pet wellness industry [1] Digital Transformation - Better Pets launched an AI-powered interactive website, mybetterpets.com, enhancing user experience and reflecting the brand's commitment to regulated pet wellness products and modern consumer engagement technology [2] - The new digital platform aims to educate pet owners on product usage, provide interactive guidance for pet care selection, enhance direct-to-consumer conversion, and support scalable e-commerce growth [11] Market Opportunity - The global pet care market is projected to exceed $250 billion by the end of the decade, driven by increased pet humanization, premiumization, and rising demand for regulated wellness products [3] - Topical care and health-support categories are among the fastest-growing segments in regulated markets, particularly in Canada and the United States [3] Product Focus and Regulatory Milestones - Better Pets confirmed ownership of over seven formulations and narrowed its commercialization focus to Pet Balm, facilitating a capital-efficient market entry [4] - The company achieved a major regulatory milestone by receiving Health Canada Veterinary Product Notification numbers for two products, validating compliance with Canadian standards [4] Brand and Distribution Strategy - Better Pets engaged Empire Media Worx for a brand modernization initiative, completing multiple branding concepts and production-ready labeling [9] - The company has developed a hybrid distribution model combining direct-to-consumer e-commerce and distributor-supported retail expansion, with Freedom Pet Supplies agreeing to carry Better Pets products in approximately 1,800–2,000 retail locations [10] Growth Strategy for 2026 - With regulatory approvals secured and digital infrastructure launched, Better Pets is focused on execution in 2026, planning initiatives for portfolio updates and market entry evaluations [12][16] - Management believes the combination of regulatory compliance, digital infrastructure, and brand modernization positions Better Pets to capitalize on the accelerating global pet wellness market and drive long-term shareholder value [13]

Group 1 - Moleculin Biotech, Inc. has entered into agreements for the immediate exercise of existing warrants to purchase up to 2,122,652 shares of common stock at an exercise price of $3.90 per share, expected to generate approximately $8.3 million in gross proceeds [1][4] - Roth Capital Partners is acting as the financial advisor for this transaction [2] - The company will issue new unregistered warrants for up to 6,367,956 shares, exercisable at the lesser of $3.90 or the lowest volume weighted average price during the next five trading days, subject to shareholder approval [3] Group 2 - The transaction is expected to close on or about February 20, 2026, pending customary closing conditions, with net proceeds intended for working capital and general corporate purposes [4] - The new warrants were offered in a private placement and have not been registered under the Securities Act of 1933, with the company agreeing to file a registration statement for the resale of shares [5] Group 3 - Moleculin Biotech is a Phase 3 clinical stage pharmaceutical company focused on developing therapeutic candidates for hard-to-treat tumors and viruses, with its lead program Annamycin targeting relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases [7][8] - The company has initiated the MIRACLE Trial, a pivotal Phase 3 trial evaluating Annamycin in combination with cytarabine for the treatment of relapsed or refractory acute myeloid leukemia, following a successful Phase 1B/2 study [8] - Additionally, the company is developing WP1066, an immune/transcription modulator targeting various cancers, and has a portfolio of antimetabolites including WP1122 for potential treatment of pathogenic viruses [9]

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, today issued the following statement on the UK Competition and Markets Authority’s (CMA) provisional decision: “We are pleased to see the CMA’s progress with respect to the proposed merger between Getty Images and Shutterstock, particularly its provisional finding that the merger is not expected to result in competition issues in the global Stock content market. We are disappoin ...

SOUTH SAN FRANCISCO, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology”; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in the Wells Fargo Executive Biotech Summit, TD Cowen 46th Annual Health Care Conference, and UBS Biotech Summit. The details of the meetings are as follows: Wells Fargo Executive Biotech Summit F ...

Waterless CO₂ Decontamination Capability Will Complement California PPE’s Advanced Wet Wash Solutions and Further Elevate Cleaning Efficacy HUNTSVILLE, Ala., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. ("Lakeland Fire + Safety" or "Lakeland") (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced that its California PPE Recon, Inc. (“California PPE”) subsidiary, which specializes in personal protective e ...

VANCOUVER, British Columbia, Feb. 19, 2026 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. ("GoldHaven" or the "Company") (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) pleased to announce that it intends to complete a non-brokered flow-through private placement financing for gross proceeds of up to $2,000,000 (the “Offering”), through the issuance of up to 7,547,170 flow-through shares at a price of $0.265 per share. The flow-through shares will qualify as “flow-through shares” within the meaning of the Income Tax Act ...

Core Insights - SEALSQ Corp has made a strategic investment in EeroQ, a quantum chip design company, as part of its "Quantum Made in USA" strategy, aiming to enhance its quantum technology capabilities [2][3][11] - EeroQ's technology focuses on a scalable quantum computing architecture using electron spins on superfluid helium, which offers advantages such as compact size and compatibility with standard semiconductor manufacturing [4][12] - The investment is part of SEALSQ's Quantum Investment Fund, which has over $100 million allocated for investing in quantum computing startups [4][9] Investment Details - SEALSQ's investment in EeroQ marks a significant milestone in its Quantum Highway strategy, which aims to create a secure path from post-quantum cryptography to quantum computing [9][11] - EeroQ has demonstrated a control architecture capable of managing up to one million qubits, addressing the "wire problem" in quantum computing [5][8] - SEALSQ has also made various investments in Europe, including approximately $12 million for a Post-Quantum Semiconductor Personalization and Test Center in Spain and $3.5 million in the Swiss-based WeCan Group [7][9] Strategic Goals - The partnership aims to build a Proof of Concept at SEALSQ's Quantum Center of Excellence in Geneva, showcasing the integration of secure semiconductor hardware and quantum processing technologies [10][11] - EeroQ's development plans align with SEALSQ's commitment to U.S.-sovereign quantum technologies, which is increasingly prioritized by governments and enterprises [11][12] - The collaboration is expected to enhance SEALSQ's ability to deliver end-to-end quantum-ready platforms for national security and critical infrastructure [11][13] Company Background - EeroQ, founded in 2017, is focused on developing large-scale quantum computers and is recognized for its ethical approach to quantum technology [14][12] - SEALSQ is a leader in post-quantum technology, integrating semiconductors and cryptographic solutions to address security challenges posed by quantum computing [16][17]